Related Experiment Video
Updated: May 27, 2026
07:22
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
2011 clinical practice guidelines for type 2 diabetes in Korea
Seung-Hyun Ko1, Sung-Rea Kim, Dong-Joon Kim
1Division of Endocrinology & Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea.
Diabetes & Metabolism Journal
|November 24, 2011
Summary
Type 2 diabetes is a growing concern in Korea. New guidelines emphasize early screening, hemoglobin A1c diagnostics, and patient self-management to combat rising prevalence and costs.
Area of Science:
- Endocrinology
- Public Health
- Clinical Medicine
Background:
- Type 2 diabetes presents a significant health challenge in Korea, marked by increasing prevalence and associated chronic complications.
- This rise in type 2 diabetes contributes to escalating healthcare expenditures and economic burdens.
Purpose of the Study:
- To outline the updated clinical practice guidelines for managing type 2 diabetes in Korea.
- To emphasize early detection strategies and improved patient care for type 2 diabetes.
Main Methods:
- Revision and update of the '3rd Clinical Practice Guidelines' by the Korean Diabetes Association Committee.
- Inclusion of hemoglobin A1c in diagnostic criteria based on Korean clinical studies.
- Development of an updated drug treatment algorithm considering hyperglycemia and patient specifics.
Main Results:
- Recommendation for active screening of high-risk individuals for early type 2 diabetes detection.
- Integration of hemoglobin A1c levels into the diagnostic criteria for type 2 diabetes.
- Emphasis on patient education and self-management as integral components of care.
Conclusions:
- The updated guidelines aim to mitigate the increasing prevalence of type 2 diabetes through early detection and enhanced management.
- Revised diagnostic and treatment strategies are crucial for addressing the growing burden of type 2 diabetes in Korea.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...